In a statement Gilead Sciences Inc, the maker of the closely-watched experimental coronavirus drug remdesivir stated, it will continue to work with international partners to expand the production of its potential COVID-19 treatment. Gilead said, it expects to have more than one million remdesivir treatment courses manufactured by December, “with plans to be able to…
Shares of Gilead Sciences Inc’s shares jumped by 16% following news reports that its experimental drug remdesivir is proving to be effective in U.S. trials of patients who have been severely afflicted by the COVID-19 disease caused by the coronavirus. According to a report from medical news website STAT, a University of Chicago hospital participating…
The U.S. Department of Health and Human Services has partnered with Regeneron Pharmaceuticals Inc to develop a treatment for the coronavirus whose outbreak in China has killed hundreds of people in China alone. The drugmaker collaboration with the U.S. Department of Health and Human Services is the latest to join the race to develop a…
business-gurus.com 